Cancer Research
Investment in cancer treatment technology, benefiting from breakthroughs and commercialization in cancer drugs, immunotherapy, and gene therapy.24H Performance
1.27%
Beta0.49
Regular Market | Last updated at Jun 25, 2026 12:56:14© 2026 Edgen Powered by